SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AFFYMETRIX (AFFX)
AFFX 14.010.0%Apr 1 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mopgcw who wrote (1517)11/25/2001 12:12:12 PM
From: tuck  Read Replies (1) of 1728
 
George,

I have spent some time recently looking more closely at the AFFX and ILMN web sites, etc. There is little doubt that ILMN's method offers some advantages, chiefly in throughput (possibly in accuracy, but I wonder if there are cross-talk issues since they still work with wells), but AFFX has a significant first mover advantage in terms of installed base, etc. ILMN barely has a product out. Scores of papers have been published listing AFFX products prominently in the "Materials & Methods" sections. Couldn't find any using ILMN's products, except those dedicated to describing ILMN's products. Further, I think LMNX is a formidable competitor. To my eye, probably less trained than yours, their technology is comparable to ILMN's and closer to commercial acceptance. Roughly analagous to the relative positions of CALP and ACLA.

I believe all three (ILMN, LMNX, and ACLA (ACLA is also a comp to ILMN, according to ILMN's 10-K)) are BLUE H stocks. So I'll add them to the WatchList there and keep a closer eye upon them.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext